Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2018

Apr 12, 2018

30597_dirs_2018-04-12_3bdd2bdd-7aa2-4531-8adb-36447719dba4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2018-04-10

Reporting Person: Doyle James Edward (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-10 Common Stock S 3098 $40.97 Disposed 35181 Direct

Footnotes

F1: The sales reported in this Column 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person to cover tax liabilities arising out of the vesting of shares of restricted stock.